US rivalry with China expands to biotech. Lawmakers see a failure to compete and want to act

Date:



U.S. lawmakers are raising alarms about what they see as America’s failure to compete with China in biotechnology, warning of the risks to U.S. national security and commercial interests. But as the two countries’ rivalry expands into the biotech industry, some say that shutting out Chinese companies would only hurt the U.S.

Biotechnology promises to revolutionize everyday life, with scientists and researchers using it to make rapid advances in medical treatment, genetic engineering in agriculture and novel biomaterials. Because of its potential, it has caught the attention of both the Chinese and U.S. governments.

This page requires Javascript.

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

Tags

  • Politics
  • The Economy
  • Trade
  • Medicine
  • Legislation
  • Law
  • Job Market
  • Armed Forces
  • Business
  • Finance
  • Institutions
  • Genetics
  • Sports
  • Sociology
  • Biotechnology
  • Industry
  • Government Departments And Ministries
  • Biology

Recommended for you

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Popular

More like this
Related

When Teachers Left My School, I Felt Like a Failure. Here’s What I Learned.

A couple of months ago, I had a conversation...

Jackson State faculty senate president sues for wrongful termination

The Jackson State University’s president and governing board are...

Students Are Unmotivated to Learn. Would Consulting Them For Curriculum Help?

Julius Cervantes, a first generation college graduate, didn’t appreciate...

From Her Perch at the Front Desk, This School Staffer Helps Kids Show Up Each Day

Nancy Muñoz is on her second act — this...